ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 962,61
0,61%
Dow Jones
38 225,66
0,85%
DAX
17 989,05
0,47%
Brent Oil
83,645
0,02%
Bitcoin
59 337,01
0,37%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cingulate Inc (CING)

  7. Cingulate Inc (CING) Actualités

CING Cingulate Inc

1,12
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:52:58
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cingulate Inc CING NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,12 10:52:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,12
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
26/2/202413:00EDGAR2Form 8-K - Current report
14/2/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202412:50EDGAR2Form 8-K - Current report
13/2/202412:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
09/2/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202412:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202422:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
05/2/202423:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202415:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202423:01EDGAR2Form SC 13D/A - General statement of acquisition of..
29/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:59EDGAR2Form S-1/A - General form for registration of securities..
29/1/202414:05EDGAR2Form 8-K - Current report
29/1/202414:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202412:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
12/1/202423:03EDGAR2Form S-1 - General form for registration of securities under..
04/1/202423:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202312:02EDGAR2Form 8-K - Current report
15/12/202314:55EDGAR2Form 8-K - Current report
12/12/202323:00EDGAR2Form 8-K - Current report
06/12/202315:00EDGAR2Form RW - Registration Withdrawal Request
01/12/202315:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
28/11/202314:45EDGAR2Form 8-K - Current report
15/11/202315:00EDGAR2Form S-1 - General form for registration of securities under..
13/11/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
03/11/202321:15EDGAR2Form 8-K - Current report
19/10/202323:00EDGAR2Form 8-K - Current report
17/10/202320:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
03/10/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202314:06EDGAR2Form PRE 14A - Other preliminary proxy statements
21/9/202319:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
19/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
18/9/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/9/202322:15GLOBECingulate Announces Closing of $4.0 Million Public Offering

Dernières Valeurs Consultées

NASDAQ
CING
Cingulate
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés